Cargando…
Design and Development of a Novel Peptide for Treating Intestinal Inflammation
Intestinal inflammatory disorders, such as inflammatory bowel disease (IBD), are associated with increased pro-inflammatory cytokine secretion in the intestines. Furthermore, intestinal inflammation increases the risk of enteric cancer, which is a common malignancy globally. Native anti-inflammatory...
Autores principales: | Zhang, Lulu, Wei, Xubiao, Zhang, Rijun, Petitte, Jim N., Si, Dayong, Li, Zhongxuan, Cheng, Junhao, Du, Mengsi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691347/ https://www.ncbi.nlm.nih.gov/pubmed/31447849 http://dx.doi.org/10.3389/fimmu.2019.01841 |
Ejemplares similares
-
A Novel Peptide Ameliorates LPS-Induced Intestinal Inflammation and Mucosal Barrier Damage via Its Antioxidant and Antiendotoxin Effects
por: Zhang, Lulu, et al.
Publicado: (2019) -
A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions
por: Wei, Xubiao, et al.
Publicado: (2020) -
Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses
por: Wei, Xubiao, et al.
Publicado: (2021) -
C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation
por: Zhang, Lulu, et al.
Publicado: (2021) -
Expression and Purification of Hybrid LL-37Tα1 Peptide in Pichia pastoris and Evaluation of Its Immunomodulatory and Anti-inflammatory Activities by LPS Neutralization
por: Ahmad, Baseer, et al.
Publicado: (2019)